Recent research demonstrate the promise of RMP1-14, a recently engineered anti-mouse PD-1 antibody , for improving malignant immunotherapy . Unlike conventional approaches, RMP1-14 exhibits increased https://www.targetmol.com/compound/anti_mouse_pd_1_antibody_rmp1_14